Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YR完成签到 ,获得积分10
6秒前
量子星尘发布了新的文献求助10
6秒前
hsiuf完成签到,获得积分10
9秒前
Zhao完成签到 ,获得积分10
9秒前
13秒前
Lrcx完成签到 ,获得积分10
19秒前
19秒前
一株多肉完成签到 ,获得积分10
19秒前
量子星尘发布了新的文献求助10
22秒前
zhang完成签到 ,获得积分10
23秒前
浮游应助明理问柳采纳,获得10
28秒前
28秒前
29秒前
峰成完成签到 ,获得积分10
29秒前
量子星尘发布了新的文献求助10
31秒前
31秒前
31秒前
chenyan完成签到,获得积分0
36秒前
库库发布了新的文献求助10
36秒前
ableyy完成签到 ,获得积分10
38秒前
量子星尘发布了新的文献求助10
39秒前
Skywalk满天星完成签到,获得积分10
43秒前
量子星尘发布了新的文献求助10
47秒前
研学弟完成签到,获得积分10
48秒前
大团长完成签到,获得积分10
51秒前
Lilian完成签到,获得积分10
53秒前
申燕婷完成签到 ,获得积分10
55秒前
易止完成签到 ,获得积分10
58秒前
baoxiaozhai完成签到 ,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
量子星尘发布了新的文献求助10
1分钟前
liaomr完成签到 ,获得积分10
1分钟前
雨前知了完成签到,获得积分10
1分钟前
我要读博士完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
网络安全 SEMI 标准 ( SEMI E187, SEMI E188 and SEMI E191.) 1000
Inherited Metabolic Disease in Adults: A Clinical Guide 500
计划经济时代的工厂管理与工人状况(1949-1966)——以郑州市国营工厂为例 500
INQUIRY-BASED PEDAGOGY TO SUPPORT STEM LEARNING AND 21ST CENTURY SKILLS: PREPARING NEW TEACHERS TO IMPLEMENT PROJECT AND PROBLEM-BASED LEARNING 500
The Pedagogical Leadership in the Early Years (PLEY) Quality Rating Scale 410
Why America Can't Retrench (And How it Might) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 催化作用 遗传学 冶金 电极 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 4612966
求助须知:如何正确求助?哪些是违规求助? 4017956
关于积分的说明 12436915
捐赠科研通 3700270
什么是DOI,文献DOI怎么找? 2040657
邀请新用户注册赠送积分活动 1073414
科研通“疑难数据库(出版商)”最低求助积分说明 957049